生物标志物 生物标志物
Roger A Dixon1, Shannon M Drouin1, Linzy Bohn1
1University of Alberta, Edmonton, AB, Canada.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
概括
来自血液和唾液的新分子生物标志物在与现有危险因素相结合时,显著改善了阿尔茨海默病的预测. 这种整合增强了早期检测,并突出了非侵入性唾液诊断的潜力.
科学领域:
- 神经科学是一个神经科学.
- 生物标志物发现发现
- 机器学习 机器学习
背景情况:
- 阿尔茨海默病 (AD) 研究越来越多地利用大型数据集来识别预测生物标志物和风险因素.
- 分析技术可以在高维数据中评估众多候选因素,以确定领先的预测因素.
- 将新型分子生物标志物与已建立的AD指标相结合,对于全面的预测建模至关重要.
研究的目的:
- 将新型分子生物标志物与已确定的阿尔茨海默病 (AD) 生物标志物和风险因素结合起来.
- 用机器学习分类器评估这些综合因素的相对预测贡献.
- 为了确定区分认知不受损,轻度认知障碍和AD状态的关键预测因素.
主要方法:
- 从COMPASS-ND数据库 (CU,MCI,AD队列) 收集了10个模式中的92个AD相关指标.
- 对血清和唾液进行了高通量代谢,确定了7000多个代谢物峰值.
- 使用了机器学习分类器 (例如,RandomForestClassifier) 具有112个预测器 (92个已确定的 + 20个新的).
主要成果:
- 所有模型都表现出高性能 (准确度,精度,AUC 0.81-0.98) 在预测AD,MCI和痴呆症.
- 可解释的人工智能 (Tree SHAP) 图表揭示了多模式预测器的歧视模式.
- 最重要的预测因素包括新型代谢物 (8/20),特别是来自唾液 (5/8),以及成像,血管和已确定的AD生物标志物.
结论:
- 来自血液和唾液的新型分子生物标志物在与已建立的AD数据集成时显示出强大的预测性能.
- 这些发现支持提升早期机械路径识别和综合性数据驱动生物标志物分析的价值.
- 非侵入性唾液生物标志物有可能提高阿尔茨海默病评估的可访问性.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516